{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:06:21Z","timestamp":1784775981498,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:00:00Z","timestamp":1474329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s12519-016-0057-3","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T14:03:46Z","timestamp":1474380226000},"page":"255-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital"],"prefix":"10.1007","volume":"13","author":[{"given":"Leelawadee","family":"Techasatian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunee","family":"Panombualert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rattapon","family":"Uppala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charoon","family":"Jetsrisuparb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"57_CR1","first-page":"173","volume":"69","author":"RA Schwartz","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol 2013;69:173.e1-173. e13.","journal-title":"J Am Acad Dermatol"},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/archdischild-2013-303718","volume":"98","author":"C Ferrandiz-Pulido","year":"2013","unstructured":"Ferrandiz-Pulido C, Garcia-Patos V. A review of causes of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children. Arch Dis Child 2013;98:998\u20131003.","journal-title":"Arch Dis Child"},{"key":"57_CR3","doi-asserted-by":"publisher","first-page":"68231","DOI":"10.1371\/journal.pone.0068231","volume":"8","author":"U Raucci","year":"2013","unstructured":"Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G, et al. Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study. PLoS One 2013;8:e68231.","journal-title":"PLoS One"},{"key":"57_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1468-3083.2010.03935.x","volume":"25","author":"C Ferr\u00e1ndiz-Pulido","year":"2011","unstructured":"Ferr\u00e1ndiz-Pulido C, Garc\u00eda-Fern\u00e1ndez D, Dom\u00ednguez-Sampedro P, Garc\u00eda-Patos V. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital. J Eur Acad Dermatol Venereol 2011;25:1153\u20131159.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"57_CR5","first-page":"e121","volume":"18","author":"BR Pozzo-Magana Del","year":"2011","unstructured":"Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, Castro-Pastrana LI, Rieder MJ. A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol 2011;18:e121\u2013e133.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"57_CR6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","volume":"71","author":"MG Kirchhof","year":"2014","unstructured":"Kirchhof MG, Miliszewski MA, Sikora S, Papp A, Dutz JP. Retrospective review of Stevens-Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. J Am Acad Dermatol 2014;71:941\u2013947.","journal-title":"J Am Acad Dermatol"},{"key":"57_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.braindev.2013.05.010","volume":"36","author":"PC Hung","year":"2014","unstructured":"Hung PC, Wang HS, Hsia SH, Wong AM. Plasmapheresis as adjuvant therapy in Stevens-Johnson syndrome and hepatic encephalopathy. Brain Dev 2014;36:356\u2013358.","journal-title":"Brain Dev"},{"key":"57_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","volume":"7","author":"AT Borchers","year":"2008","unstructured":"Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev 2008;7:598\u2013605.","journal-title":"Autoimmun Rev"},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ophtha.2014.08.013","volume":"122","author":"DH Kim","year":"2015","unstructured":"Kim DH, Yoon KC, Seo KY, Lee HS, Yoon SC, Sotozono C, et al. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens- Johnson syndrome. Ophthalmology 2015;122:254\u2013264.","journal-title":"Ophthalmology"},{"key":"57_CR10","first-page":"195","volume":"38","author":"MR Tagajdid","year":"2013","unstructured":"Tagajdid MR, Doblali T, Elannaz H, Hammi S, Belfequih B, Mrani S. Reactivation of cytomegalovirus in a patient with stevens-johnson syndrome-toxic epidermal necrolysis. Iran J Med Sci 2013;38(2 Suppl):195\u2013197.","journal-title":"Iran J Med Sci"},{"key":"57_CR11","first-page":"1298","volume":"29","author":"T Shirai","year":"1991","unstructured":"Shirai T, Sato A, Okano A, Honda K, Chida K, Iwata M, et al. Fulminant mycoplasma pneumoniae infection presenting with Stevens-Johnson syndrome & respiratory failure. Nihon Kyobu Shikkan Gakkai Zasshi 1991;29:1298\u20131304.","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","volume":"62","author":"LW Yip","year":"2007","unstructured":"Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, et al. Ocular manifestations and complications of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: an Asian series*. Allergy 2007;62:527\u2013531.","journal-title":"Allergy"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/BCR.0b013e31827a2ac3","volume":"34","author":"GM Hamilton","year":"2013","unstructured":"Hamilton GM, Fish J. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit. J Burn Care Res 2013;34:e351\u2013e358.","journal-title":"J Burn Care Res"},{"key":"57_CR14","first-page":"S85","volume":"94","author":"S Singalavanija","year":"2011","unstructured":"Singalavanija S, Limpongsanurak W. Stevens-Johnson syndrome in Thai children: a 29-year study. J Med Assoc Thail 2011;94 Suppl 3:S85\u2013S90.","journal-title":"J Med Assoc Thail"},{"key":"57_CR15","first-page":"207","volume":"149","author":"L Naldi","year":"2014","unstructured":"Naldi L, Crotti S. Epidemiology of cutaneous drug-induced reactions. G Ital Dermatol Venereol 2014;149:207\u2013218.","journal-title":"G Ital Dermatol Venereol"},{"key":"57_CR16","first-page":"399","volume":"96","author":"J Thammakumpee","year":"2013","unstructured":"Thammakumpee J, Yongsiri S. Characteristics of toxic epidermal necrolysis and Stevens-Johnson syndrome: a 5-year retrospective study. J Med Assoc Thai 2013;96:399\u2013406.","journal-title":"J Med Assoc Thai"},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1365-4632.2010.04481.x","volume":"49","author":"WY Ding","year":"2010","unstructured":"Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol 2010;49:834\u2013841.","journal-title":"Int J Dermatol"},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","volume":"364","author":"P Chen","year":"2011","unstructured":"Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011;364:1126\u20131133.","journal-title":"N Engl J Med"},{"key":"57_CR19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","volume":"51","author":"W Tassaneeyakul","year":"2010","unstructured":"Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin S-Y, Chen W-H, et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 2010;51:926\u2013930.","journal-title":"Epilepsia"},{"key":"57_CR20","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","volume":"9","author":"PB Ferrell","year":"2008","unstructured":"Ferrell PB, McLeod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 2008;9:1543\u20131546.","journal-title":"Pharmacogenomics"},{"key":"57_CR21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/epi.12325","volume":"54","author":"W Rattanavipapong","year":"2013","unstructured":"Rattanavipapong W, Koopitakkajorn T, Praditsitthikorn N, Mahasirimongkol S, Teerawattananon Y. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. Epilepsia 2013;54:1628\u20131638.","journal-title":"Epilepsia"},{"key":"57_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149\u2013153.","journal-title":"J Invest Dermatol"},{"key":"57_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jaad.2009.06.085","volume":"62","author":"MJ Koh","year":"2010","unstructured":"Koh MJ, Tay YK. Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children. J Am Acad Dermatol 2010;62:54\u201360.","journal-title":"J Am Acad Dermatol"},{"key":"57_CR24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/ijd.12118","volume":"53","author":"P Su","year":"2014","unstructured":"Su P, Aw CW. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study. Int J Dermatol 2014;53:1339\u20131345.","journal-title":"Int J Dermatol"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-016-0057-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-016-0057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-016-0057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T08:58:30Z","timestamp":1526547510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-016-0057-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1007\/s12519-016-0057-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726782364.793576497","asserted-by":"object"}]},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}